Author | Lynda Charters


Taking a step forward in diagnostic testing and disease monitoring

Home testing technology is proving to be a key advancement in monitoring and screening glaucoma patients.

Intravitreal pegcetacoplan proves useful for geographic atrophy: Phase 3 results of OAKS and DERBY studies

At ASRS 2021, Dr David Boyer reported that pegcetacoplan used to treat geographic atrophy and administered in monthly or every-other-month regimens was well tolerated in patients in the phase 3 DERBY and OAKS studies.

PDS with ranibizumab in nAMD offers similar results to ranibizumab monthly injections

Dr Arshad Khanani reported at ASRS 2021 that the Port Delivery System with ranibizumab, an investigational product that continuously delivers ranibizumab intravitreally, achieved results similar to those in patients treated with monthly ranibizumab injections for nAMD.